NEBRASKA ONCOLOGY SOCIETY (EIN 470772122) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2010

Legal Domicile

Principal Officer

AMY REYNOLDSON

Phone

4024744472

Tax Period

2024-01-01 to 2024-12-31

NEBRASKA ONCOLOGY SOCIETY, founded in 2010, is a small nonprofit that reported $300K in total revenue in fiscal year 2024. Revenue fell 22% from the prior year — a significant decline worth monitoring. The organization ran a surplus of $96K, a strong 32% operating margin.

Mission

TO FACILITATE AND PROMOTE INTERACTION AMONG THE ONCOLOGY COMMUNITY TO ENHANCE PATIENT CARE THROUGH ONCOLOGY RESEARCH, EDUCATION, AND HEALTH CARE LEGISLATION.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $216,950

Program Service Revenue $33,775

Investment Income $48,904

Other Revenue $0

TOTAL REVENUE $299,629

Expense Breakdown

Grants Paid $6,823

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $197,233

TOTAL EXPENSES $204,056

Year-over-Year Comparison

	2024	2023	Change
Revenue	$299,629	$382,910	-0.2%
Expenses	$204,056	$252,442	-0.2%
Net Income	$95,573	$130,468	-0.3%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
STEFANO R TARANTOLO MD	PRESIDENT	1.00	Officer Director	$0	$0	$0
RALPH HAUKE MD	VICE PRESIDENT	1.00	Officer Director	$0	$0	$0
YUNGPO BERNARD SU MD	SECRETARY/TREASURER	1.00	Officer Director	$0	$0	$0
SAMER RENNO MD	MEMBER AT LARGE	1.00	Director	$0	$0	$0
ROBERT LANGDON JR MD	MEMBER AT LARGE	1.00	Director	$0	$0	$0
RYAN RAEMAKERS MD	MEMBER AT LARGE	1.00	Director	$0	$0	$0
IFRAN VAZIRI MD	MEMBER AT LARGE	1.00	Director	$0	$0	$0
CARMEN CHINCHILLA-GUTIERREZ	EXECUTIVE DIRECTOR	1.00	Officer	$0	$0	$0
AMY REYNOLDSON	EXEC. VP	1.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$299,629	$204,056	$1,618,721	$95,573
2023	$382,910	$252,442	$1,532,212	$130,468
2022	$257,327	$171,244	$1,401,743	$86,083
2021	$263,096	$141,255	$1,315,660	$121,841
2020	$231,841	$132,403	$1,193,819	$99,438
2019	$151,971	$117,134	$1,094,381	$34,837
2018	$189,999	$204,980	$1,059,544	$-14,981

NEBRASKA ONCOLOGY SOCIETY